EnteroMedics Inc.
ETRM
ETRM was delisted on the 20th of October, 2017.
56 hedge funds and large institutions have $23.5M invested in EnteroMedics Inc. in 2014 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 12 increasing their positions, 15 reducing their positions, and 15 closing their positions.
948% more call options, than puts
Call options by funds: $1.55M | Put options by funds: $148K
7% less first-time investments, than exits
New positions opened: 14 | Existing positions closed: 15
2% less funds holding
Funds holding: 57 → 56 (-1)
20% less repeat investments, than reductions
Existing positions increased: 12 | Existing positions reduced: 15
38% less capital invested
Capital invested by funds: $38.1M → $23.5M (-$14.6M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FAM
Fred Alger Management
New York
|
+$1.16M |
| 2 |
SC
Sophrosyne Capital
New York
|
+$535K |
| 3 |
JGC
J. Goldman & Co
New York
|
+$374K |
| 4 |
RSCM
Rock Springs Capital Management
Baltimore,
Maryland
|
+$357K |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
+$180K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AAP
Ardsley Advisory Partners
Stamford,
Connecticut
|
-$6.44M |
| 2 |
Wells Fargo
San Francisco,
California
|
-$1.94M |
| 3 |
IHM
Iguana Healthcare Management
New York
|
-$980K |
| 4 |
WPC
White Pine Capital
Bloomington,
Minnesota
|
-$738K |
| 5 |
GTC
Ghost Tree Capital
New York
|
-$728K |
ETRM Hedge Fund Activity: Q2 2014 in Review
56 of the 3,491 institutional investors tracked by Wall St. Rank reported a position in EnteroMedics Inc. (ETRM) for Q2 2014, worth a combined $23.5M — down 38% from $38.1M a quarter earlier.
Sellers outnumbered buyers: 15 funds closed out of ETRM and 14 opened new positions — a net loss of 1 holder — while 15 trimmed existing stakes and 12 added.
The largest buyer was Fred Alger Management, opening a new position worth an estimated $1.16M. The largest seller was Ardsley Advisory Partners, cutting an estimated $6.44M.
- 56 institutional investors held EnteroMedics Inc. (ETRM) as of Q2 2014, down from 57 in Q1 2014.
- Funds reported $23.5M of EnteroMedics Inc. stock for Q2 2014, down 38% quarter-over-quarter.
- 14 funds opened new EnteroMedics Inc. positions in Q2 2014 and 15 closed out, a net change of -1 holder.
- The largest EnteroMedics Inc. buyer in Q2 2014 was Fred Alger Management, an estimated $1.16M added.
- The largest EnteroMedics Inc. seller in Q2 2014 was Ardsley Advisory Partners, an estimated $6.44M sold.
Based on aggregated 13F filings for Q2 2014.